STAAR Surgical CEO, Tom Frinzi Discusses Exciting Growth and Developments for 2023
During the ASCRS meeting in San Diego, Mark Kontos, MD talked with Thomas G. Frinzi, Chair of the Board, President and Chief ...
Advisor, STAAR SURGICAL CO
Search every verified Thomas Frinzi interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a September 2023 interview, Thomas Frinzi, Chair of the Board, President and CEO of STAAR Surgical, discussed the company's recent performance and developments. He stated that the company had a strong first quarter with 20 percent growth globally, noting that China, a major market, had recovered from a dip in late 2022, and that the U.S. market grew by 78 percent year over year. Frinzi said the company had invested in its U.S. team by adding practice development personnel, clinical applications staff, territory managers, and new executives, which he described as raising the quality of the team. Frinzi attributed increased adoption of the EVO ICL lens to expanded digital marketing and direct-to-consumer advertising, as well as the procedure's simplification due to the elimination of the peripheral iridotomy. He cited 99.4 percent patient satisfaction and two million implants worldwide, adding that no ophthalmologist had expressed dissatisfaction with the lens's quality of vision. Frinzi described the current period as an exciting time to be associated with STAAR Surgical.
During the ASCRS meeting in San Diego, Mark Kontos, MD talked with Thomas G. Frinzi, Chair of the Board, President and Chief ...
This OIS On-Sight Interview features Tom Frinzi, Worldwide President, Surgical Johnson & Johnson Vision at OIS@AAO 2018.
Ophthalmology veteran Tom Frinzi joins OIS.TV to share his reasons for joining Abbott Medical Optics and what the company may be planning in coming years. For more on Ophthalmology Innovation News & Events visit: http://ois.net/ Video Highlights: 00:32 – What brought you to AMO? 1:20 – What are the three Ps? 2:02 – Is there a formula for leading any a company? 3:51 – How has ophthalmology changed as a specialty? 4:45 – What makes ophthalmology unique? 5:40 – Where will you be looking for innovation? 6:25 – Where are the disruptive opportunities? 7:16 – What are you introducing at ASCRS? 7:41…
Sign in to search the full transcript archive, filter by topic, and access every quote from Thomas Frinzi.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans